Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
Provided By GlobeNewswire
Last update: Nov 21, 2024
IRVINE, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical technology company, announces they have recently received three patent notices of allowance covering technology and methods for treating Gastroesophageal Reflux Disease (“GERD”), Crohn’s Disease, and Ulcerative Colitis using its proprietary inFoods® Technology. These patents apply to countries under the European Patent Organization (“EPO”), including major markets such as Germany, UK, France, Italy, and Spain, as well as over 30 other nations within the EPO.
Read more at globenewswire.comNASDAQ:BMRA (4/21/2025, 2:11:37 PM)
3.44
+2.96 (+616.67%)
Find more stocks in the Stock Screener
BMRA Latest News and Analysis
4 days ago - ChartmillWondering what's happening in today's after-hours session?The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
5 days ago - ChartmillHere are the top movers in Wednesday's session.Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.
5 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.Intrigued by the market activity in the middle of the day on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
5 days ago - ChartmillWhich stocks are gapping on Wednesday?Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
